[1] 王晔,王大海,魏胜男,等.首发未用药精神分裂症与精神分裂症患者健康子女静息态脑功能低频振幅研究[J].中国神经精神疾病杂志,2016,42(6):342-346. [2] KahnRS, KeefeRS. Schizophrenia is a cognitive illness: time for a change in focus[J].JAMA Psychiatry,2013, 70(10): 1107-1112. [3] 赵艳.利培酮与9-羟利培酮对精神分裂症患者血药浓度与剂量关系的探讨[J].中国现代药物应用,2012,6(20):73. [4] 中华医学会精神科分会.中国精神障碍分类与诊断标准[M].济南:山东科技出版社,2001:48-49. [5] Chien WT, Lee IY. The schizophreia care management program for family care givers of Chinese patients with schizophrenia [J].Psychiatr SERV,2010, 61(3): 317-320. [6] 高静芳,陶明,李翼群,等.智能筛选测验的信度和效度测试[J].中华精神科杂志,1997,30(3):175-178. [7] 郭鑫,黄继蔷,袁宁.利培酮对首发精神分裂症患者的疗效及认知功能的影响[J].中国现代医生,2016,54(5):86-88. [8] 彭成国,肖寒,杨媚,等.齐拉西酮与利培酮对男性精神分裂症患者糖脂代谢及性激素水平的影响[J].海南医学院学报,2015,21(12):1720-1722,1726. [9] Olivier MR, Killian S, Chiliza B,et al. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study[J].Psychol Med,2015, 45(13): 2873-2883. [10] 曹颖,刘士玲.利培酮治疗首发精神分裂症疗效分析及对血清心肌标志物的影响[J].海南医学院学报,2015,21(4):559-561,564. [11] 赵燕,刘辉,李旸,等.利培酮治疗首发精神分裂症停药前用药时间与临床疗效的关系[J].国际精神病学杂志,2016,43(3):411-414. [12] 赵瑾,张燕,晁阳阳,等.利培酮和奥氮平对首发精神分裂症患者治疗前后认知功能的影响[J].中华医学杂志,2016,96(37):2960-2964. [13] 范银莹,刘家洪,高智勇,等.利培酮对精神分裂症合并糖尿病患者的疗效及认知功能的影响[J].中国现代医生,2016,54(23):78-81. [14] Sakurai H, Suzuki T, Bies RR, et al. Increasing versus maintaining the dose of olanzapine or risperidone in schizophrenia patients who did not respond to a modest dosage: a double-blind randomized controlled trial [J].J Clin Psychiatry,2016, 77(10): 1381-1390.
2017, Vol. 34 
